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Summary
The retinoic acid receptor (RAR) is a member of the nuclear receptor superfamily. This ligand-inducible transcription factor binds to
DNA as a heterodimer with the retinoid X receptor (RXR) in the nucleus. The nucleus is a dynamic compartment and live-cell
imaging techniques make it possible to investigate transcription factor action in real-time. We studied the diffusion of EGFP–RAR by
fluorescence correlation spectroscopy (FCS) to uncover the molecular interactions determining receptor mobility. In the absence of
ligand, we identified two distinct species with different mobilities. The fast component has a diffusion coefficient of
D151.826.0 mm2/second corresponding to small oligomeric forms, whereas the slow component with D250.0520.10 mm2/second
corresponds to interactions of RAR with the chromatin or other large structures. The RAR ligand-binding-domain fragment also has a
slow component, probably as a result of indirect DNA-binding through RXR, with lower affinity than the intact RAR–RXR complex.
Importantly, RAR-agonist treatment shifts the equilibrium towards the slow population of the wild-type receptor, but without
significantly changing the mobility of either the fast or the slow population. By using a series of mutant forms of the receptor with
altered DNA- or coregulator-binding capacity we found that the slow component is probably related to chromatin binding, and that
coregulator exchange, specifically the binding of the coactivator complex, is the main determinant contributing to the redistribution of
RAR during ligand activation.
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Introduction
Nuclear receptors are transcription factors that are able to
regulate the expression of their target genes by direct DNA-
binding in a ligand-dependent manner. An important subgroup of
this protein superfamily is that of retinoid receptors including
retinoic acid (RARa, RARb and RARc) and retinoid x receptors
(RXRa, RXRb and RXRc), which play a central role in
endocrine signaling, regulation of embryonic and adult
development, and myeloid cell differentiation (Mangelsdorf
et al., 1995). RXR acts as a heterodimerization partner for
several types of nuclear receptors. Retinoid receptors possess two
well-conserved domains present in all nuclear receptors: the
DNA-binding domain (DBD) and the ligand-binding domain
(LBD) at the C-terminus of the protein. The DBD contains two
zinc-finger motifs and is linked to the LBD by a highly flexible
hinge region. The LBD shows a greater diversity among nuclear
receptors because it is a site for receptor-specific ligand binding.
It possesses transactivation activity through the activation
function 2 (AF-2) domain and contains a ligand-binding pocket
as well as the main interaction surfaces for dimerization and
coregulator binding. The C-terminal helix (H12) of the LBD was
found to be essential for coregulator exchange (Love et al., 2002).
Our current view of nuclear receptor action is largely defined by
the rather rigid molecular switch model, which describes the
course of events taking place during activation of receptors (Nagy
et al., 1999). According to this model, retinoid receptors are bound
to both DNA and corepressors in the unliganded (repressed) state.
SMRT (silencing mediator of retinoic acid and thyroid hormone
receptor) and N-COR (nuclear receptor corepressor) are key
corepressors in this system and they harbor two interaction
domains (IDs) that make direct interaction with nuclear receptors
possible. At the same time, these corepressors can also serve as
docking sites for additional components of a corepressor complex
such as histone deacetylases, allowing the formation of large
protein complexes (Chen and Evans, 1995). Based on structural
studies, the model proposes that ligand binding induces a more
tightly packed conformation of the receptor with the H12 bound to
the receptor’s surface. In this new conformation, the receptor has a
decreased affinity towards corepressors and acquires a binding
surface for coactivators such as ACTR (activator for thyroid
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hormone and retinoid receptors) or DRIP/TRAP (Onate et al.,
1995; Heery et al., 1997; Darimont et al., 1998; Rachez et al.,
1998). The coactivator serves as a docking surface for additional
components of the activator complex, histone acetyltransferases,
chromatin remodeling factors and the basic transcriptional
machinery (Gottlicher et al., 1998; Hermanson et al., 2002). This
model suggests a rather rigidly predetermined sequence of events
taking place on the receptor, which is sitting statically on its
response element.
As a result of the ever increasing number of identified
coregulators, and the numerous complexes with which they can
associate, it has become evident that there must be some
functional redundancy and a greater flexibility in coregulator–
receptor interactions. The potential of combinatorial regulation,
the high 3D flexibility of receptors and the determining role of
local nuclear architecture all point towards the formulation of a
more flexible and dynamic model. Most importantly, the
contribution of diffusion and mobility in the nucleus has not
been accounted for in most of the models proposed, which have
been largely based on transfection and biochemical analyses, as
well as protein structures (Sprague et al., 2004).
However, biophysical methods such as fluorescence recovery
after photobleaching (FRAP) studies opened up the sub-second
range of events by reporting that glucocorticoid receptors (GRs)
show characteristic residence times of seconds on response
element arrays. This challenge of the rigid model of stably
formed complexes bound to DNA led to the proposal of the hit-
and-run model, suggesting the existence of a highly dynamic
system (McNally et al., 2000). The immobile fraction and half-
recovery time of labeled molecules give a hint about their
dynamics. By developing more elaborate diffusion models for
FRAP, it is now becoming possible to distinguish several
diffusion components (Axelrod et al., 1976; Lippincott-
Schwartz et al., 2003). However if a mixture of distinct
populations were analyzed as a single species, the calculated
average diffusion time would not represent a biologically
meaningful parameter, or would at least obscure the real
molecular behavior of the system.
Somewhat contrary to these results, which suggest rapid
exchange of transcription factors on the promoter, systematic
chromatin immunoprecipitation (ChIP) experiments were able to
show the cyclic features of the mobility of chromatin remodeling
proteins and transcription factors on the time scale of tens of
minutes (Hinojos et al., 2005; Metivier et al., 2006). As it was
pointed out, the latter findings might reflect different equilibrium
states and their changes, but not the dynamic behavior of these
proteins (Gelman et al., 2006). These studies clearly suggest that
further biophysical analysis of the diffusion of these molecules is
necessary.
To study and measure multicomponent diffusion, we applied
fluorescence correlation spectroscopy (FCS), which is a
fluorescence microscopy technique having single-molecule
sensitivity. It uses the fluctuation of fluorescence intensity
resulting from the diffusion of fluorescently labeled molecules
in and out of a confocal (subfemtoliter-sized) volume (Brock
et al., 1999; Vamosi et al., 2009). The recorded fluorescence
signal is used to extract an autocorrelation function (ACF), which
reflects the photophysical and diffusion properties of the
molecules. By fitting the autocorrelation curves to various
diffusion models, it is possible to determine diffusion times,
calculate diffusion coefficients and the fractions of molecules in
each subpopulation characterized by distinct diffusion parameters
(Lippincott-Schwartz et al., 2001; Hess and Webb, 2002; Bacia
and Schwille, 2003; Berland, 2004). To monitor the dynamic
features of human RARa (referred to as RAR here), expression
vectors coding for the fusion proteins of fluorophores (EGFP,
mCherry) and the receptor (human RARa) or coregulator
(ACTR, SMRT) interaction domains were constructed. We
found a fast population corresponding to smaller complexes or
dimers, and a slow population, which probably reflects chromatin
binding. By mapping the diffusion behavior of various functional
mutants of the receptor with altered DNA- or coregulator-binding
capacities, we have defined the factors determining receptor
mobility. Ligand-induced transition to the slow population
depends on the co-activator binding capacity of the receptor.
Results
Two distinct populations of EGFP–RAR with different
mobility are indicated by fits of FCS autocorrelation curves
Our first aim was to determine the main characteristics of RAR
mobility in single cells using FCS. For these studies, we used
HeLa cells stably expressing EGFP–RAR. Confocal microscopic
images of EGFP–RAR showed clear nuclear localization and a
homogenous distribution within the nucleus (Fig. 1A). By
contrast, the truncated form, comprising the LBD only, was
also present in the cytoplasm (Fig. 1B). Each form was excluded
from the nucleoli. The averaged autocorrelation curves were
fitted to different types of diffusion models: one-component free
diffusion, one-component anomalous diffusion and two-
component free diffusion. The residuals show systematic
deviations for the one-component fits (Fig. 2A,B). In addition,
they also have larger chi-square values than the two-component
fit. Chi-square values were the lowest for the two-component
model for the different mutant forms of the receptor as well
(supplementary material Table S1). Comparison of the one-
component free diffusion, two-component free diffusion and one-
component anomalous diffusion models with F-test or corrected
Aikaike’s Information Criteria also supported the two-component
model. Nuclear receptors participate in various complexes during
their function; thus a multicomponent model is plausible. We
also tested a two-component anomalous diffusion model. The
anomaly parameters showed large standard deviation (data not
shown), including values a.1 for the fast component, hinting at
directed motion, which we cannot interpret in our model system.
Fig. 1. Localization of EGFP–RAR. Confocal images of HeLa cells
expressing (A) EGFP–RAR or (B) EGFP–RAR-LBD taken with an Olympus
FV 1000 microscope (EGFP fluorescence, Ex. 488 nm, Em. 500–530 nm).
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Thus, autocorrelation curves of EGFP–RAR were accounted for
by a two-component free diffusion model, which gave a tight fit
throughout the curve (Fig. 2C). Including a third diffusion
component did not improve the fit, or had such a low
amplitude that no reliable diffusion time could be determined.
Mobility parameters for the wild-type and mutant receptors
derived from the two-component free diffusion model are shown
in Table 1. (For a comparison of mobility parameters determined
by the two-component free diffusion and one-component
anomalous models, see supplementary material Table S2.)
Diffusion times were in the range of t151.5–5 mseconds and
t2575–150 mseconds for the faster and the slower population
corresponding to diffusion coefficients of D151.8–6 mm2/second
and D250.06–0.12 mm2/second, respectively. We also determined
the diffusion time and diffusion coefficient of EGFP alone
(D513 mm2/second), according to the one-component free
diffusion model. (The fits of a representative EGFP autocorrelation
curve and the residuals of the fits are shown in supplementary
material Fig. S1.) From the diffusion times we assessed the masses of
the diffusing complexes (see Eqn 5 in the Materials and Methods).
These calculations were based on assuming a spherical shape for the
complex, which may not hold exactly true, but allows an estimation
of the order of magnitude of the mass.
The apparent molecular masses of diffusing EGFP–RAR
complexes were calculated by comparing their diffusion times
with that of EGFP. The apparent masses for both populations
turned out to be larger than that of a monomeric EGFP–RAR,
51 kDa. The ratio of this apparent molecular mass and the real
molecular mass gives us the number of receptors (or molecules
in the complex having an equivalent mass) that are expected to
have the measured diffusion time. This ratio is 5–10 in the
fast population, which might represent receptor oligomers or
receptors bound to smaller complexes. In the case of the slower
population, this ratio is as high as 106 (Fig. 3A). The existence of
such a large diffusing complex is unlikely, suggesting that
transient or stable interactions with the chromatin or other
practically immobile structures take place.
Considering a two-component model, another important aspect
is the distribution of receptors among the fast and slow
populations. r1 describes the fraction of molecules with the
shorter diffusion times (‘fast population’) and r2 represents the
fraction with the larger diffusion times (‘slow population’),
summing up to 100%. For a complete overview of the
distributions of the diffusion times we plotted their relative
frequency histograms (Fig. 3B). As shown, ,30% of EGFP–
RAR belongs to the slow population in absence of ligand
(Fig. 3C). Neither the diffusion times, t1 and t2, nor their
population ratios, r1 and r2, showed any correlation with the
average number of molecules (N) in the detection volume
characterizing the concentration (supplementary material Fig.
S2A–C). This proves that the detected diffusion times and the
fractions of slow and fast species are not due to artifacts such as
large aggregates that could occur as a result of overexpression. In
our analysis we included only measurements where the value of
N was in the range of 20–50. EGFP–RAR-expressing cells
showed a threefold increase in RAR mRNA level compared with
levels in the nontransfected cells, as determined by quantitative
RT-PCR (supplementary material Fig. S3). RAR protein
expression increased twofold in cells stably transfected with
GFP–RAR, as shown by immunofluorescence imaging
(supplementary material Fig. S4, Table S3).
Fig. 2. Nonlinear fitting of EGFP–RAR autocorrelation curves to
diffusion models. (A) Fit of EGFP–RAR FCS autocorrelation curve with the
one-component, anomalous-diffusion model. Below the residuals are shown
(x2533). (B) Fit with the one-component, free-diffusion model (x25103).
(C) Fit with the two-component, free-diffusion model (x2526).
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Activation of RAR changes population ratios but not
diffusion times
A central concept of nuclear receptor action is the molecular
switch model describing ligand-dependent coregulator exchange
as the main event that makes activation possible. Next, we
investigated how this event is reflected by the mobility of RAR.
Treatment with a saturating concentration of a selective RAR
agonist (100 nM AM580) caused only a slight change in
diffusion times. As the diffusion time distribution histogram
shows, it is the transition from the fast to the slow population
rather than the change of the diffusion times that principally
hallmarks receptor activation. As a result of agonist treatment, a
significant, ,10% increase was detected in the ratio of the slow
population (Fig. 3B,C). The increase of r2 was found to be
specific for the RAR-agonist. No change of r2 was detected after
RAR antagonist (AGN109) treatment, indicating that enhanced
co-repressor binding is not influencing the mobility and
distribution of the receptors and also confirms the absence of
endogenously produced agonist ligands. In addition, treatment
with RXRa agonist (LG268) or PPARc agonist (Rosiglitazone)
also induced no change, showing the specificity of RAR-selective
ligand treatment (Fig. 4A). The RAR-agonist-induced increase of
r2 was detectable as early as 10 minutes after treatment, and was
still present 120 minutes later. This effect was detectable
for AM580 concentrations .1 nM, and was saturated around
10–100 nM (Fig. 4B). The increase of r2 persisted even after
washing out the ligand with ligand-free medium (Fig. 4C). Based
on these results 100 nM ligand concentration was used for
receptor activation in subsequent FCS experiments.
Changing coregulator-binding capacity alters the
equilibrium between the fast and slow components
The characteristic change correlated with ligand-dependent RAR
activation is the increase of the slow population r2; thus our aim
was to find the key factors that determine this phenomenon.
According to the molecular switch model of nuclear receptors,
the main feature of the mechanism is coregulator exchange,
which could also affect receptor dynamics. The process of
receptor activation consists of corepressor release and subsequent
coactivator binding, accompanied by a conformational change of
the receptor. Previously, we reported that mutations of RAR
Table 1. Mobility parameters of wild type and mutant EGFP–RAR
100 nM AM580 t1 (mseconds) r2 t2 (mseconds) n
EGFP–RAR – 2.64¡0.65 29¡7% 97¡57 420
EGFP–RAR + 2.87¡0.99 43¡9% 89¡45 340
EGFP–RAR-A392R – 2.69¡0.73 27¡8% 108¡81 117
EGFP–RAR-A392R + 2.83¡0.92 39¡11% 92¡56 80
EGFP–RAR-W225A – 2.64¡1.07 22¡8% 119¡81 90
EGFP–RAR-W225A + 2.54¡0.5 26¡7% 127¡80 87
EGFP–RAR-V395A – 2.66¡1.29 20¡8% 120¡112 130
EGFP–RAR-V395A + 2.65¡0.84 19¡9% 116¡121 140
EGFP–RAR-dH12 – 2.83¡0.81 26¡7% 120¡62 130
EGFP–RAR-dH12 + 3.17¡0.84 27¡7% 124¡58 130
EGFP–RAR-mZn – 2.89¡0.7 29¡6% 105¡61 130
EGFP–RAR-mZn + 3.40¡0.99 35¡9% 111¡61 110
EGFP–RAR-LBD – 1.62¡0.62 17¡11% 99¡101 150
EGFP–RAR-LBD + 2.05¡1.20 27¡15% 114¡138 150
Data represent the parameters of EGFP–RAR before (2) and 10 minutes after (+) the addition of 100 nM AM580 derived from fitting all the measurements
done to the two-component free diffusion model. Data are mean ¡ s.d. In each cell, two to three points were selected for FCS measurements. Thus n values
represent ,2–36 the number of measured cells.
Fig. 3. Mobility parameters of EGFP–RAR. (A) Diffusion coefficients of
the EGFP molecule determined by the one-component free-diffusion model,
compared with the fast and slow component of EGFP–RAR molecule,
determined by the two-component free-diffusion model. Fast population:
t151.5–5 mseconds, D151.8–6 mm2/second. Slow population: t2575–
150 mseconds, D250.05–0.1 mm2/second. (B) Distribution of diffusion times
of EGFP–RAR before (solid line) and 10 minutes after (dotted line) the
addition of 100 nM AM580. (C) Fraction of the slow population before (gray)
and 10 minutes after (black) addition of 100 nM AM580 (data are means ¡
s.d.; ***P,0.001).
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affect co-factor binding in specific ways (Benko et al., 2003).
Based on this knowledge, we created a series of (EGFP-fused)
point mutants modified at the surface residues of the fourth and
eleventh helix of the RAR ligand-binding domain (Fig. 5). RAR-
A392R is reported to be a mutant with an affinity for coactivators
higher than that of the wild type. Its ‘apo’ (unliganded) form is
unable to bind corepressor, but shows an increased affinity for
coactivators. The latter interaction gets even more robust when
agonist is present. This mutant had an increased transactivating
ability compared with that of the wild type (supplementary
material Fig. S5). RAR-W225A shows an increased affinity for
the SMRT corepressor, thus being unable to release it upon
ligand treatment. Therefore, agonist-dependent coregulator
exchange cannot take place, rendering this mutant to lose its
activity (supplementary material Fig. S5). RAR-V395A shows a
greatly reduced affinity for corepressors as well as coactivators
and is called a no-coregulator-binding mutant. All the point
mutants showed nuclear localization and a distribution that was
Fig. 4. Dependence of population ratios of EGFP–RAR on type and dose of ligand, and mode of activation. (A) Fraction of the slow population (r2) before
(gray, vehicle) and after addition of 100 nM of the indicated ligands: synthetic (AM580) and natural (ATRA, all-trans retinoic acid) RARa-agonists, RARa-
antagonist (AGN109), synthetic RXRa-agonist (LG268) and PPARc-agonist (Rosiglitazone). (B) Dose dependence of the rearrangement of EGFP–RAR
population ratios 10 minutes after addition of (1029 to 1025 M) AM580. (C) Fraction of the slow population following pulsed ligand treatment. No ligand, before
ligand treatment; AM580 I, 10 minutes after the addition of 100 nM AM580 for the first time; washed out, 20 minutes after the medium was replaced with ligand-
free medium; AM580 II, 10 minutes after the second AM580 treatment (data are means ¡ s.d.; ***P,0.001).
Fig. 5. Representation of mutant forms of RAR.
(A) Ribbon representation of RAR ligand binding
domain (PDB number, 3KMZ), showing the positions of
W225A, V240A and A392R mutations and RAR DNA
binding domain with its response element (PDB number,
1YNW), showing the positions of the four cysteines
(red) within the first zinc-finger that were substituted
with alanines. (B) Schematic representation of the RAR
molecules used in this study (the EGFP moiety is
not shown).
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Fig. 6. See next page for legend.
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similar to the wild type (data not shown). FCS measurements of
nuclei transiently transfected with mutant forms of EGFP–RAR
were carried out in the absence and presence of 100 nM AM580.
First we compared the diffusion properties of the untreated wild-
type receptors and mutants with modified coregulator-binding. In
the case of the ‘activator-binding’ mutant (A392R), the diffusion
properties of the untreated receptor were similar to those of the
wild type. On average, r2530% of the population showed slow
diffusion before ligand treatment. Apparently, the loss of repressor
binding did not have a dramatic effect on the dynamics of the
receptor (Fig. 6A). By contrast, the increased SMRT-binding
affinity of the ‘repressor-binding’ mutant (W225A) caused a slight
increase in t2 and a slight decrease of r2 (25%) for the untreated
sample (Fig. 6B). The third, ‘cofactor-non-binding’ mutant
(V395A) showed a further decreased level of r2 (,20%)
represented by a very low peak in the histogram (Fig. 6C).
The mutants showed a clearly disparate behavior after AM580-
treatment. A clearly significant increase of r2 (,12%) could only
be detected in the case of the ‘activator-binding’ mutant, which
behaved similarly to the wild type (Fig. 6G). The repressor-
binding mutant had a smaller increase of r2 (,4%), and no
change was detected for the ‘cofactor-non-binding’ mutant.
Based on these results we assumed that there is a strong
connection between coactivator binding and the ligand-induced
increase of the ratio of the slow population.
To further test this hypothesis, we studied the behavior of a
mutant lacking the C-terminal helix 12 (H12) (Fig. 5B). H12 has a
key role in the action of nuclear receptors as molecular switches.
Upon ligand binding, it folds on the receptor similarly to the lever
of a mouse-trap, forming a new interface for the coactivator to
bind. Corepressor binding and active H12 conformation are
mutually exclusive. Deletion of H12 results in a nonfunctional
form of RAR that is unable to release the corepressor and bind
coactivators. The diminished coactivator binding ability provided
us with another aspect to investigate the connection between
coactivator binding, activity and mobility of RAR. In the apo state,
r2 was slightly smaller for the DH12-mutant (26%) than for the
wild type, and the increase of r2 was nearly completely abolished
(Fig. 6D,G). These features resemble the constitutive repressor-
binding mutant, corroborating the connection between the ligand-
induced redistribution of populations, coactivator binding capacity
and activity (supplementary material Fig. S5). As seen from these
results, mutations of the coregulator binding capacity changed the
fraction of the slower, assumedly chromatin-bound component.
Next, we tested mutants where the DNA-binding affinity of the
receptor was directly altered.
Impaired DNA-binding gradually reduces the slow
population, but does not abolish ligand-induced
redistribution of populations
The DNA-binding domain of RAR has two zinc-finger motifs,
each with four coordinating cysteine residues (Fig. 5). Mutation of
all four cysteines to alanines in the first zinc finger led to a
dramatic decrease in the activating capacity of the receptor, as
demonstrated by the transient transfection analysis (supplementary
material Fig. S5). The zinc-finger mutant showed nuclear
localization when transfected into HeLa cells. According to the
FCS measurements, this mutant behaved similarly to the wild type
RAR: 29% of the unliganded receptors belonged to the slower
population, but only a slight increase (6%) was measured after
ligation. The change of distribution was smaller, but still
statistically significant (Fig. 6E,G).
To completely abolish the direct DNA-binding capacity of the
receptor, we examined the properties of the EGFP-tagged ligand-
binding domain (LBD) of RAR (Fig. 5). Interestingly, this
molecule still had residual activity (supplementary material Fig.
S5) and showed a ligand-induced increase of r2. As presented in
the diffusion time distribution histogram, losing almost one half
of the receptor and its direct DNA-binding capacity yielded a
characteristic change. The ratio of the slower population in the
untreated sample dropped to 17%. At the same time, an
activation-dependent increase of r2 could still be detected, but
reached a significantly lower level (27%) than that of the full-
length receptor (Fig. 6F). Because the LBD has no direct DNA-
binding capacity, the ligand-induced redistribution to the slow
state is probably due to dimer formation with RXR and binding to
DNA through its dimerization partner. The fractions of the slow
populations of the different mutant forms of EGFP–RAR with or
without agonist treatment are summarized in Fig. 6G and
Table 1. In summary, direct binding to chromatin is an
important factor in determining the distribution of receptors
among the fast and slow populations, but it is not the key
determinant factor in the ligand-induced redistribution.
Full-length coactivator binding is indispensable for
ligand-enhanced increase of the slow population
To gain more direct evidence for the role of cofactor binding in
the distribution among the fast and slow states of RAR, we
carried out competition experiments. We cotransfected mCherry-
labeled, short coregulator peptides, the nuclear receptor binding
interaction domains (IDs) of coregulators with an additional
consensus nuclear localization signal: mCherry-NLS-ACTR-
ID1+2 and mCherry-NLS-SMRT-ID1+2. These IDs bind to
both members of the RAR–RXR dimer, but lack the domains
responsible for docking further proteins of the transcription
machinery. We monitored the expression level of the peptides
through the fluorescence of mCherry. Labeled coregulator IDs
showed nuclear localization (data not shown). The receptor-
binding ability of the peptides was proven by the two-hybrid
system competition assay (supplementary material Fig. S6).
Cotransfection of either coregulator-peptide (ACTR-ID
coactivator and SMRT-ID corepressor) decreased r2 by ,5% in
the absence of ligand as compared with the wild type, and as the
graph in Fig. 7A shows, it caused no major changes in the
diffusion time distribution of unliganded receptors. It seems that
Fig. 6. Diffusion time distributions of the wild type and mutated forms of
EGFP–RAR. (A) The activator-binding mutant (A392R, with elevated
activator-binding affinity). (B) The repressor-binding mutant (W226A, with
elevated repressor-binding affinity). (C) The cofactor non-binding mutant
(V395A, with decreased coregulator-binding ability). (D) The helix-12 (AF2)-
deleted mutant (with no ability for coregulator-exchange). (E) The Zn-finger
mutant (with a reduced DNA-binding ability). (F) The ligand binding domain
construct (LBD, with no direct DNA-binding capacity). Distributions of
diffusion times of the mutant forms before (solid line) and 10 minutes after
the addition (dotted line) of 100 nM AM580 are shown. Columns
representing the wild type EGFP–RAR before (gray) and after (black) the
addition of 100 nM AM580 are shown for comparison. The positions of the
columns mark the average diffusion times (t1 and t2), and the heights of the
columns are equal to the heights of the peaks shown in Fig. 3B of wild-type
EGFP–RAR. (G) Summary of the changes in population ratios of wild-type
and mutant forms of EGFP–RAR. See Table 1 for detailed results. (Data are
means ¡ s.d., ***P,0.001; *P,0.1.)
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receptors behave similarly in the presence of full-length
corepressor or the short repressor ID in the absence of ligand. In
the presence of ligand, the repressor peptide probably dissociates,
giving way to agonist-induced binding of the coactivator, which is
similar to the case when no repressor peptide was cotransfected
(Fig. 7A,B). By contrast, when coactivator peptide is
cotransfected, the agonist induced increase of r2 is not observed
(Fig. 7A,C). Binding of the short interaction domain of the
activator is insufficient to the formation of the full activation
complex. These results are consistent with our assumption that
the ligand-induced redistribution between the fast and slow
populations depends on binding full-length coactivator.
Discussion
The use of modern fluorescence microscopy techniques in
transcription regulation research has allowed the mobility and
interactions of molecules inside the cell to be assessed
(Houtsmuller and Vermeulen, 2001; Lippincott-Schwartz et al.,
2001; Schwille, 2001; van Roessel and Brand, 2002). A good
example of the progress made is the case of the estrogen receptor
(ERa). This receptor has been extensively studied and its nuclear
localization and agonist-dependent speckle formation were
described (Stenoien et al., 2000). Moreover, multiple diffusion
components have been resolved using fluorescence microscopy
techniques; primarily FRAP and FCS (Jankevics et al., 2005).
Using FRAP measurements it was shown that unliganded ERa
exhibited high mobility, and agonist treatment resulted in slower
recovery of fluorophore-fused ERa after bleaching compared
with the untreated state. It was also shown that the CFP–lacER
chimera, which is immobilized at the lac promoter, can trigger
agonist-dependent immobilization of SRC-1 activator by binding
it to the nuclear receptor (Stenoien et al., 2001). The high
intranuclear mobility of both nuclear receptors and coregulators
was demonstrated for GR and GRIP-1 in another system (Becker
et al., 2002). Biphasic models for the evaluation and fitting of
FRAP curves were suggested, reflecting the scanning motion and
transient engagement of proteins (Karpova et al., 2004). Based on
these and other studies, as well as experiments with an MMTV-
promoter array, the so called hit-and-run model was proposed
(McNally et al., 2000). The FCS method allows the determination
of local diffusion times of fluorescently labeled molecules.
Diffusion time distribution analysis showed that co-existence of
different states of the same nuclear receptor (ER) results in
populations with distinct diffusion times (Jankevics et al., 2005).
Three major states were described, namely small complexes and
dimers; ligand-induced larger complexes; and the chromatin-
bound population. Based on FRAP analysis of various chromatin
proteins (structural, remodeling, coactivators, transcription
factors) transient binding with characteristic short and long
residence times was suggested (Phair et al., 2004). In this
scenario, stably formed protein–protein or protein–DNA
complexes are replaced by highly mobile, stochastically formed
complexes. The dynamic concept of gene expression is largely
influenced by the time resolution of available methods. The
concept of transcription factors that cycle in a 30–60 minute
period is mainly based on chromatin immunoprecipitation results.
This is complemented by FRAP measurements, which add a new
dimension of molecular dynamics. Although several studies have
been carried out on nuclear receptors using the repertoire of
fluorescence microscopy, the picture is not yet complete. FCS
Fig. 7. The effect of cotransfected coregulator peptides on the ligand-
induced r2-increase of EGFP–RAR. (A) Ratios of the slow population (r2)
of EGFP–RAR alone or with the cotransfection of repressor peptide
(mCherry-NLS-SMRT-ID1+2) or activator peptide (mCherry-NLS-ACTR-
ID1+2) respectively, before (gray) and 10 minutes after (black) the addition of
100 nM AM580 (data are mean ¡ s.d.; ***P,0.001). (B) Distribution of
diffusion times of EGFP–RAR with or without the cotransfection of repressor
peptide (mCherry-NLS-SMRT-ID1+2). (C) Distribution of diffusion times of
EGFP–RAR with or without the cotransfection of activator peptide (mCherry-
NLS-ACTR-ID1+2). Columns representing the wild type EGFP–RAR before
(gray) and after (black) the addition of 100 nM AM580 are shown for
comparison. The positions of the columns mark the average diffusion times
(t1 and t2), and the heights of the columns are equal to the heights of the
peaks shown in Fig. 3B of wild-type EGFP–RAR.
Journal of Cell Science 124 (21)3638
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
can further increase the time resolution of these studies, yielding
well-defined diffusion times in the millisecond range.
In this article we focused on RAR and described the
characteristic features of RAR mobility. EGFP-fused RAR
showed nuclear localization just like PPARs, RXR and TR
(Akiyama et al., 2002; Maruvada et al., 2003). Speckle formation
is a typical phenomenon that is not always interpreted the same
way. In most cases, the flakes formed by nuclear receptors turned
out to be pools of proteins caused by overexpression (Feige et al.,
2005). We did not detect any speckle formation either in the
absence or in the presence of agonist ligand, which shows that the
expression level was low enough not to perturb the normal spatial
distribution of the receptor in the nucleus. Transcriptional
activities of the EGFP-tagged chimeras were virtually identical
to the non-tagged forms when tested in transient transfection
assays.
In FCS, finding the appropriate diffusion model is a critical
issue. Several models have been applied in different studies,
examining GR, PPAR and other transcription factors such as Jun
and Fos (Baudendistel et al., 2005; Vamosi et al., 2008). These
included free-diffusion models with one, two or three
components and also anomalous diffusion models (Mikuni
et al., 2007; Tudor et al., 2007). The latter is described by the
anomaly coefficient (a), a51 representing free diffusion. The
case a,1 is called anomalous subdiffusion, which can be caused
by molecular crowding or transient binding. Fitting our
autocorrelation curves to the two-component free-diffusion
model resulted in the least noisy residual curves with the best
fit, as mentioned above. In good correlation with the earlier NR
mobility studies discussed above, our FCS measurements
described a two-component system with average diffusion
times of 1.5–5 mseconds and 75–150 mseconds. These
populations might represent the receptors in smaller diffusing
complexes (monomers, dimers, small regulator complexes or a
mixture of these) and ones that are bound to larger complexes
and/or exhibit a stronger affinity towards the chromatin (and are
likely to be transiently bound to it). It is important to point out
that, from a biological perspective, the difference between a one-
component anomalous and a two-component free diffusion model
is minute. Assuming two distinct components (Jankevics et al.,
2005) is justified if we consider that the receptor can be in (at
least) two different states, e.g. as a monomer, dimer or small
complex, or as part of a repressor–activator complex bound
transiently or stably (on the time scale of FCS) to the chromatin.
However, the one-component anomalous diffusion model
(Gelman et al., 2006) also assumes stochastic transient binding,
resulting in some molecules diffusing more slowly across the
detection volume, whereas others that escape binding diffuse
faster, broadening the decay of the autocorrelation curve. Thus,
both models can describe the system appropriately.
In previous FRAP studies (Maruvada et al., 2003; Gelman
et al., 2006), no increase in the average diffusion time of RAR
was detected after agonist treatment, in contrast to ER, AR or GR
(Dong et al., 2004). Here we reported a characteristic increase by
10%, resulting in a final value of 40% of the slow population of
RAR. The described agonist-induced effect on RAR mobility can
only be seen by FCS, and appears to be undetectable by FRAP.
We suggest that this slow population includes the
transcriptionally competent fraction of the receptors.
Besides characterization of the diffusion properties of the
receptor, we also sought to find the main determinants that affect
these properties. We created a set of point mutants to probe this.
The mutations that resulted in a reduced activator binding ability
(repressor-binding mutant and H12-deleted mutant) caused the
loss of agonist-dependent increase in r2, but also caused a slight
increase in t2 and a slight decrease of r2, in the unliganded state. A
plausible explanation for this effect could be that, owing to its
higher corepressor binding affinity (smaller koff), these mutants
might spend more time bound to the corepressor, thereby reducing
the number of corepressors available at any given time point.
Therefore, the r2 fraction of receptors participating in corepressor
complexes in the time window of FCS (,100 mseconds)
decreases, and the apparent diffusion time t2 of the receptors
within corepressor complexes increases. This latter phenomenon
can also be an indication of the increased affinity of the receptor–
corepressor complex to the chromatin compared with that of the
receptor not binding corepressor. This notion is also supported by
the reduced r2 of the cofactor-non-binding mutant.
We showed that the loss of direct DNA-binding ability had a
significant effect on the redistribution among fast and slow
populations. The protein containing only the LBD of the receptor
also showed an increase in r2, but t2 became shorter, suggesting
that the residence time on chromatin was reduced. Owing to the
fact that the LBD has no direct DNA-binding capacity, DNA
binding is probably facilitated by RXR, the heterodimerization
partner of RAR. The DNA-binding affinity of RXR alone is
apparently lower than that of the intact RAR–RXR dimer,
resulting in a shorter residence time (shorter t2) on the chromatin.
Interestingly, for LBD, t1 is also reduced compared with wild-
type RAR, which cannot be explained by its smaller molecular
mass alone; rather the LBD resides in the low-mobility
complexes (bound to chromatin, or to coregulators) for shorter
time spans. The shortening of t1 as a result of the loss of the
DNA-binding domain might also indicate that the wild-type
receptor is transiently bound to chromatin, not only in the slow
state but, with a much reduced residence time, also in the fast
state. This might explain why the fast component of the wild-type
receptor is found to be slower than would be expected for a freely
diffusing monomer.
The most likely and our favored scenario is that the ligand-
induced increase of the slower population is very closely linked
to coactivator binding (Fig. 8). By cotransfecting the interaction
domains of the coactivator to RAR, we have managed to compete
the endogenous coactivators from the receptors in the ligand-
binding state, thus abolishing the redistribution of populations. In
the presence of the endogenous full-length coactivators, the
formation of the complete, functional coactivator complex is
possible (by binding of further proteins); however, the
coactivator-interaction domain lacks the binding surfaces for
the additional components of the complex. Thus, the peptide-
bound receptors cannot seed the full activator complex, and this
is why the described redistribution of receptors cannot be
detected. In this regard, it is important to note the unique nature
of RAR among nuclear receptors: it is very potent in mediating
both repression and activation of transcription. Therefore, the
differences between the actions of nuclear receptors have to be
taken into consideration when formulating a general concept of
transcription dynamics.
Our conclusion is that the detected, agonist-dependent increase
in the ratio of the slower population shows correlation with
coactivator binding (and possibly dimerization). We would like
to put forward the model that the key determinants of RAR
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mobility in the nucleus are chromatin-binding and receptor-
coregulator interactions. Without the activating signal, the
scanning activity dominates, which means that the equilibrium
of populations of molecules with different diffusion times is
mainly determined by weak, transient chromatin binding.
However, coregulator binding is also present in this state, and
becomes more pronounced when activation takes place. As the
agonist ligand is bound to the ligand-binding pocket of the
receptor, and it changes the conformation of the LBD, the
coregulator-exchange can take place and coactivator is bound.
This exchange affects the interaction of not only two proteins, but
the entire complex of proteins. This change of the local nuclear
environment results in a higher DNA-binding affinity of the
receptor, replacing the scanning-like weak binding with a
potentially stronger one that might consequently lead to the
activation of the basic transcriptional machinery and the initiation
of transcription. Obviously, this model needs refinement and
further testing by FCS as well as FCCS or FRET techniques, in
which co-mobility and colocalization of the receptors with
cofactors as well as chromatin proteins and DNA should be
determined.
Materials and Methods
Cell culture and transfection
RAR mobility was studied in live HeLa cells. Cells were maintained in Phenol-
Red-free RPMI, supplemented with 10% fetal calf serum, 2 mM glutamine,
penicillin and streptomycin. Cells were plated 48 hours before measurement into
Nunc eight-well coverglass plates. 24 hours later, at 70% confluency, transfection
was performed using 40 ng DNA mixed with 0.16 ml FuGene (Roche) per well.
A stable transfectant cell line of EGFP–RAR was created by G418 selection.
HeLa cells were transfected with EGFP–hRARa plasmids using FuGene in T25
flasks. Two days later dead cells were removed and the original culture was diluted
and moved to separate 25 cm2 Petri dishes. After 2 days of culture neomycin
selection was applied, and passaged cells were cultured with 800 mg/ml G418
(Sigma) from this point. Selective medium was refreshed every other day and cells
were passaged every 4 days. This selection was continued for 3 weeks to remove
most of the EGFP–RAR-negative cells. After the selection period, one week was
allowed for colony formation. Each colony thus contained the descendants of one
stably transfected cell. Colonies were picked from the Petri dishes using cloning
rings, and were plated in 24-well plates. Several colonies were picked and cultured
to reach at least 80% confluency inside the wells. The ratio of EGFP–RAR positive
to negative populations and the distribution of intensity levels of the colonies were
characterized by flow cytometry. A population with a narrow distribution of
EGFP–RAR expression was sorted and propagated for subsequent experiments.
Plasmid constructs
cDNAs encoding human RARa, human RARa-LBD (containing only the ligand-
binding domain), human RARa-DH12 (lacking helix-12 responsible for activator
binding), cofactor interaction domains with nuclear localization signal NLS-
hSMRT-ID and NLS-hACTR-ID (Benko et al., 2003) were subcloned after PCR
amplification into pEGFP–C3 (Clontech) and pmCherry-C3 (created from pEGFP–
C3 by replacing EGFP with mCherry) using BglII and HindIII for RAR constructs,
XhoI and HindIII for SMRT, and NheI and SacI for ACTR constructs. EGFP–RAR
mutants were created using the QuikChange Site-Directed Mutagenesis Kit
(Stratagene) according to the manufacturer’s instructions. Integrity of all plasmids
was confirmed by DNA sequencing. Expression vectors for transient transfection
assays, Gal-SMRT-ID1+2, VP-hRARa-LBD, CMX-hRARa, pMH100-TK-luc,
bRARE-luc, pCMX-b-galactosidase, Gal-ACTR-ID1+2, were described
previously (Chen and Evans, 1995) and were kindly provided by Ronald M.
Evans (Salk Institute for Biological Studies, La Jolla, CA, USA).
Transient transfection assay
Functional characterization of proteins was performed by cotransfecting 500 ng of
the cDNA with 120 ng of reporter retinoic acid response element (RARE) and
90 ng of the b-galactosidase plasmid into COS-1 cells in 96-well plates. Luciferase
activity was determined in the lysates using the Luciferase Assay Kit (Promega).
Measurements were made with a Wallac Victor2 multilabel counter. The detected
fluorescence is proportional to the transactivating ability of RARE-bound RAR.
The signal of each sample was normalized to b-galactosidase activity to take the
transfection efficiency and cell viability into account. Transient transfections were
carried out in triplicate (Nagy et al., 1999).
Real-time RT-PCR
Total RNA was isolated with TRIzol reagent. Reverse transcription was performed
at 42 C˚ for 1 hour and 72 C˚ for 5 minutes from 200 ng of total RNA using
Superscript II reverse transcriptase. Quantitative PCR was performed, as reported
previously (Szatmari et al., 2006).
Immunofluorescence detection of RAR in non-transfected and stably
transfected (sGFP–RAR) cells
Cells were fixed with 3.7% formaldehyde (4 C˚, 10 minutes), permeabilized with
0.25% Triton and 0.1% TWEEN/TBS (room temperature, 30 minutes), blocked
with 2% BSA with 0.1% TWEEN/TBS (room temperature, 30 minutes). Cells
were then incubated with rabbit polyclonal anti-RARa antibody (C-20, Santa Cruz
Biotechnologies, Santa Cruz, CA) at 1:200 dilution (room temperature, 1 hour),
followed by incubation with ATTO633-conjugated anti-rabbit IgG for 1 hour at
room temperature. Between consecutive steps cells were washed three times with
PBS. Confocal images of labeled cells were taken with an Olympus FV1000
confocal microscope (EGFP fluorescence, Ex. 488 nm, Em. 500–530 nm;
ATTO633, Ex. 633 nm, Em. 650–750 nm). Average pixel intensities in
uniformly sized ROIs were determined with the ImageJ software and were
corrected for background by subtracting the average intensity of cells incubated
with the secondary antibody alone. Relative expression levels of the non-
transfected and transfected cell lines were compared based on the corrected
average intensities.
Fig. 8. Interpretations of the different states and
populations of RAR as detected by FCS. The
nucleus is depicted here in the absence (left side) or
presence of a ligand for RAR. Left, the majority of the
receptors (NR) in their unliganded state are present in
a monomeric/dimeric form or as small complexes (the
latter species is not shown in the figure). Freely
diffusing receptors and maybe DNA-scanning
receptors with short residence times on DNA represent
the ‘fast diffusing population’ (upper, blue-shaded
area). The ‘slow population’ (lower, brown-shaded
area) probably corresponds to repressor-bound
molecules, which can probably bind to chromatin with
longer residence times than the ones in the ‘fast
population’. Right, the fraction of this slow population
is increased when the receptor binds an agonist (red
dot). In the activated state the size of the population
that exhibits a longer residence time on chromatin and
interacts with activator proteins increases (as indicated
by the larger brown area).
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Pulsed ligand treatment
Transfected cells were incubated with 100 nM AM580 ligand in serum-free
medium for 10 minutes before FCS measurements. FCS measurements (see next
section) were carried out for 40 minutes afterwards. After washing out the ligand
with pre-warmed (37 C˚) HBSS-buffer cells were kept in serum-free medium in a
CO2 incubator at 37 C˚ for 20 minutes. FCS measurements were then carried out in
the absence of ligand for 40 minutes. Cells were treated again with ligand, and
after incubation for 10 minutes they were measured with FCS.
Fluorescence correlation spectroscopy instrumentation and measurements
FCS measurements were performed on a modified Olympus FluoView 1000
confocal microscope based on an inverted IX-81 stand with an UPlanAPo 606
NA 1.2 water immersion objective. The two-channel FCS extension (prototype
designed by Jo¨rg Langowski, Steinbeis Transfer Center for Biophysical Analytics,
Heidelberg, Germany) is attached to the fourth detection channel of the confocal
scanning unit. FCS measurements on live HeLa cells were performed in eight-well
chambered coverglass plates described above. Fluorescence of EGFP was excited
by the 488 nm line of an Ar ion laser, and emission was detected through a 500–
550 nm band-pass filter by a Perkin-Elmer avalanche photodiode (Perkin-Elmer,
Wellesley, MA). Fluorescence autocorrelation curves were calculated online by an
ALV-5000E correlator card (ALV-Laser Vertriebsgesellschaft, Langen, Germany).
Measurements of 1068 second runs were taken at three selected points in the
nucleus of each selected cell.
Data analysis
‘Good’ autocorrelation curves from the 1068 second runs were selected and
averaged by the Correlation Run Select software (written by Ka´roly Mo´dos,
Semmelweis University, Budapest, Hungary). Runs displaying large deviations
from the average correlation curves because of rare events (large fluorescence
fluctuations caused e.g. by aggregates) were excluded from the analysis. Nonlinear
fitting of multiple runs at a selected point was carried out on the averaged
autocorrelation curves using the QuickFit software (by Michael Tewes and Malte
Wachsmuth, DKFZ, Heidelberg, Germany). For fitting the autocorrelation curves
of EGFP-labeled RAR molecules a model with two diffusion components, triplet
correction and a term taking account of EGFP blinking was used:
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The autocorrelation function can be broken down to a term accounting for triplet
state formation and dark state formation due to protonation (or light-induced
transition to a non-emitting state) also called blinking, and a term accounting for
diffusion (Gdiff). N is the average number of dye molecules in the detection volume, t
is the lag time. In the triplet term T denotes the equilibrium molar fraction of
fluorophores in the triplet state and ttr is the triplet lifetime (Widengren and Rigler,
1998). Two independent protonation mechanisms: an intramolecular proton transfer
and a pH-dependent external protonation process have been described (Haupts et al.,
1998). Because the characteristic time constants of the two protonation processes are
separated by less than an order of magnitude at pH 7.4, a single term, characterized
by the molecular fraction Hc and the correlation time tc was considered.
In the diffusion terms G
free
diff and G
anomal
diff the diffusion of two species has been
assumed: a fast one with a mole fraction r1 and diffusion time t1, and a slow one with a
mole fraction r2512r1, and diffusion time t2. Including a third diffusion component
did not improve the fit significantly and yielded very low amplitudes for the third
component, rendering the fit unreliable. S denotes the ratio of the longitudinal vs.
radial diameters of the ellipsoid-shaped detection volume (defined by the surface of
e22 detection efficiency relative to the center of the illuminated spot). The exponent a
accounts for the mechanism of diffusion; a51 for free (Brownian) diffusion, a,1 for
obstructed diffusion (Wachsmuth et al., 2000). For free diffusion, the mean-squared
displacement is a linear function of the time, i.e. the diffusion coefficient is
independent of the traveled distance. Anomaly means that the diffusion coefficient
becomes exceedingly smaller for diffusion over longer distances. Anomalous diffusion
can result from transient binding or molecular crowding.
The diffusion of EGFP in the nucleus was fitted to a single-diffusion component
model with triplet and blinking correction. Histograms of diffusion time
distributions were created as follows. Each decade was divided to five bins
having equal width on a logarithmic scale. t1 and t2 values derived from the
nonlinear fits contributed to the appropriate bins (containing t1 or t2) by the
weights of the components, r1 and r2, respectively. To make histograms smoother,
the bins were shifted in five equal steps on a log scale, and in each step the actual
height was assigned to the centre of the bin. Finally, the sum of the frequencies of
all bins was normalized to unity. Thus, the relative frequencies belonging to the
peak of the fast or slow diffusion time add up to r1 and r2, respectively. This
procedure resulted in an optimal nonparametric estimator of the probability density
function of our data (Venables and Ripley, 1997). The average weights of the slow
fraction, r2, were also presented as bar graphs.
The diffusion coefficient Di (i51,2) of a fluorescent species can then be
assessed as:
Di~v
2
xy
.
4tið Þ ð4Þ
where vxy is the lateral radius of the detection volume. vxy at 488 nm excitation
was estimated from the diffusion of Alexa Fluor 488 (50 nM solution dissolved
in 10 mM Tris-EDTA buffer, pH 7.4), and calculating vxy~
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,191 nm, where D was taken from the literature
(D5414 mm2/second at 25 C˚) (Petrov, 2008).
The apparent molecular mass of the receptor or receptor complex, assuming a
spherical shape for the diffusing species was assessed from the diffusion times by
using the following relation based on the Stokes–Einstein equation:
M
apparent
EGFP{RAR

MEGFP~ DEGFP=DEGFP{RARð Þ3~ tEGFP{RAR=tEGFPð Þ3 ð5Þ
where MEGFP527 kDa is the molecular mass of EGFP, and tEGFP-RAR and tEGFP
are their respective diffusion autocorrelation times determined from the nonlinear
fits.
Statistical analysis to compare the averages of best fit parameters was carried
out with unpaired t-tests using the Graphpad Prism software. Comparison of
different diffusion models was carried out with an F-test (one-component free
diffusion vs two-component free diffusion, one-component free diffusion vs one-
component anomalous diffusion) or with corrected Aikaike’s information criteria
(two-component free vs one-component anomalous diffusion) using an online
calculator (Graphpad Software, http://www.graphpad.com/quickcalcs/AIC2.cfm).
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Table S1. Chi-squared values of the fits of wild type and mutated EGFP-RAR
autocorrelation
curves with different diffusion models
 
AM580
one-component
free
anomalous
two-component
free
EGFP  - 41.9 37.2 21.3
 - 103.1 33.3 25.9
EGFP-RAR
 + 80.2 35.4 25.7
 - 91.3 33.7 24.2
EGFP-RAR-AR
 + 87.9 32.7 23.5
 - 79.5 33.7 26.6
EGFP-RAR-VA
 + 76.7 30.6 26.1
 - 89.0 59.0 21.4
EGFP-RAR-WA
 + 92.9 65.0 20.7
 - 77.4 26.1 20.4
EGFP-RAR-dH12
 + 78.3 27.0 23.0
 - 65.5 35.9 21.8
EGFP-RAR-LBD
 + 70.9 33.0 23.7
 - 68.0 28.9 24.9
EGFP-RAR-mZN
 + 69.9 30.4 25.1
Table S2. Mobility parameters of wild-type and mutated EGFP-RAR with different
diffusion models. Data represent the best-fit parameters to the one-component
anomalous
2-component free diffusion anomalous diffusion
 
100 nM AM580
_1 (ms) _2 (ms) r2 _ (ms)
EGFP-RAR  - 2.64 ± 0.65 97 ± 57 29% ± 7% 2.68 ± 1.8
EGFP-RAR  + 2.87 ± 0.99 89 ± 45 43% ± 9% 12.8 ± 9.23
 - 2.69 ± 0.73 108 ± 81 27% ± 8% 2.67 ± 1.23EGFP-RAR-A392R
(activator binding mutant)
 + 2.83 ± 0.92 92 ± 56 39% ± 11% 7.73 ± 5.39
 - 2.64 ± 1.07 119 ± 81 22% ± 8% 2.19 ± 1.93EGFP-RAR-W225A
(repressor binding mutant)
 + 2.54 ± 0.5 127 ± 80 26% ± 7% 1.78 ± 1.65
 - 2.66 ± 1.29 120 ± 112 20% ± 8% 2.16 ± 1.23EGFP-RAR-V395A
(cofactor non-binding mutant)
 + 2.65 ± 0.84 116 ± 121 19% ± 9% 2.56 ± 1.33
 - 2.83 ± 0.81 120 ± 62 26% ± 7% 2.9 ± 1.4EGFP-RAR-dH12
(Helix-12 deleted mutant)
 + 3.17 ± 0.84 124 ± 58 27% ± 7% 3.46 ± 1.47
 - 2.89 ± 0.7 105 ± 61 29% ± 6% 3.42 ± 0.58EGFP-RAR-mZn
(Zinc-finger mutant)
 + 3.40 ± 0.99 111 ± 61 35% ± 9% 6 ± 3.16
 - 1.62 ± 0.62 99 ± 101 17% ± 11% 2.07 ± 3.4EGFP-RAR-LBD
(ligand binding domain only)
 + 2.05 ± 1.20 114 ± 138 27% ± 15% 2.81 ± 3.4
Table S3. Comparison of RAR-expression in non-trasfected (HeLa) and stable
transfectant (sGFP-RAR HeLa) cell lines based on confocal microscopic evaluation
of fluorescence intensities from immunolabeled RAR
 Intensity
 Mean s.d.
Control 60 6
HeLa 225 19
sEGFP-RAR HeLa 380 38
 
Corrected
HeLa 165
sEGFP-RAR HeLa 320  
   
Ratio of expression
(sEGFP-RAR-HeLa/HeLa) 2  
